---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-010173"
form_type: "8-K/A"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:52:17.139441+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health issues $350K in 6% notes with warrants; corrects prior filing dates

## Summary
- Issued $350,000 aggregate principal amount of 6% unsecured promissory notes to two accredited investors.
- Warrants to purchase up to 350,000 shares at $1.00 per share, exercisable immediately, expire in 5 years.
- Proceeds used for working capital and general corporate purposes; transaction closed on January 6, 2026.
- This 8-K/A corrects scrivener's errors in the original filing regarding execution and closing dates.

## SEC filing metadata
- accession: 0001193125-26-010173
- form_type: 8-K/A
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526010173/0001193125-26-010173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526010173/jagx-20260106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-010173
- JSON: https://secwatch.observer/filing/0001193125-26-010173.json
- Plain text: https://secwatch.observer/filing/0001193125-26-010173.txt

## Key facts
- Debt Financings
  Jaguar Health, Inc. incurred loan of $350,000 aggregate principal amount with two accredited investors at 6% per annum maturing one month after issuance.
  - Instrument: loan
  - Principal: $350,000 aggregate principal amount
  - Counterparty: two accredited investors
  - Rate: 6% per annum
  - Maturity: one month after issuance
  - Event: incurrence
  source text: On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526010173/0001193125-26-010173-index.htm
- Material Agreements
  Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 aggregate principal amount (effective 2026-01-06).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: two accredited investors
  - Value: $350,000 aggregate principal amount
  - Effective: 2026-01-06
  source text: On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526010173/0001193125-26-010173-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.